<?xml version="1.0" encoding="UTF-8"?>
<ClinicalDocument xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <realmCode code="US"/>
  <typeId root="2.16.840.1.113883.1.3" extension="POCD_HD000040"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.1" extension="2015-08-01"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.9" extension="2015-08-01"/>
  <id root="a2407a0d-bbd6-4986-b54c-8c1df48d43fd"/>
  <code code="11506-3" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="Progress note"/>
  <title>SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Wilma Mankiller</title>
  <effectiveTime value="20260323120000-0500"/>
  <confidentialityCode code="N" codeSystem="2.16.840.1.113883.5.25"/>
  <languageCode code="en-US"/>
  <setId root="04df35e5-5cb4-47a0-9c41-7aa17c57bb95"/>
  <versionNumber value="1"/>
  <recordTarget>
    <patientRole>
      <id root="4fe565cc-0bef-43be-ade3-fd9e41828ea2" extension="HR-ML052-SYN"/>
      <id root="2.16.840.1.113883.4.1" extension="000-52-4183"/>
      <addr nullFlavor="UNK"/>
      <telecom nullFlavor="UNK"/>
      <patient>
        <name use="L"><given>Wilma</given><family>Mankiller</family></name>
        <administrativeGenderCode code="F" codeSystem="2.16.840.1.113883.5.1" displayName="Female"/>
        <birthTime value="19911118"/>
        <raceCode nullFlavor="ASKU"/>
        <ethnicGroupCode nullFlavor="ASKU"/>
        <languageCommunication><languageCode code="en"/><preferenceInd value="true"/></languageCommunication>
      </patient>
      <providerOrganization>
        <id root="6a7f851b-842b-45d7-9552-3e8582647414"/>
        <name>St. Posthumous Health Center</name>
      <telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr>
      </providerOrganization>
    </patientRole>
  </recordTarget>
  <author>
    <time value="20260323120000-0500"/>
    <assignedAuthor><id root="5351d0d4-bba3-49fe-9064-662e8ab964f0"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Rena</given><family>Hawkfeather-Lindqvist</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedAuthor>
  </author>
  <custodian>
    <assignedCustodian><representedCustodianOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedCustodianOrganization></assignedCustodian>
  </custodian>
  <legalAuthenticator>
    <time value="20260323120000-0500"/>
    <signatureCode code="S"/>
    <assignedEntity><id root="5351d0d4-bba3-49fe-9064-662e8ab964f0"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Rena</given><family>Hawkfeather-Lindqvist</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity>
  </legalAuthenticator>
  <documentationOf>
    <serviceEvent classCode="PCPR"><templateId root="2.16.840.1.113883.10.20.21.3.1"/><effectiveTime><low value="20260323"/><high value="20260323"/></effectiveTime><performer typeCode="PRF"><assignedEntity><id root="5351d0d4-bba3-49fe-9064-662e8ab964f0"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Rena</given><family>Hawkfeather-Lindqvist</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></performer></serviceEvent>
  </documentationOf>
  <componentOf>
    <encompassingEncounter>
      <id root="c75e5612-5828-46ac-a004-5efb4b4a1664"/>
      <code code="390906007" codeSystem="2.16.840.1.113883.6.96" displayName="Follow-up encounter"><originalText>Two-week review with the neuromuscular neurology consultation the same day: antibody, nerve stimulation, chest CT and kidney ultrasound results, the diagnosis, and the treatment plan</originalText></code>
      <effectiveTime><low value="20260323"/><high value="20260323"/></effectiveTime>
      <encounterParticipant typeCode="ATND"><assignedEntity><id root="5351d0d4-bba3-49fe-9064-662e8ab964f0"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Rena</given><family>Hawkfeather-Lindqvist</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></encounterParticipant>
      <location><healthCareFacility><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><serviceProviderOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></serviceProviderOrganization></healthCareFacility></location>
    </encompassingEncounter>
  </componentOf>
  <component>
    <structuredBody>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.1.13.2.1"/>
    <code code="10154-3" codeSystem="2.16.840.1.113883.6.1" displayName="Chief complaint Narrative - Reported"/>
    <title>Chief Complaint</title>
    <text><paragraph>Two-week review: antibody, nerve stimulation and imaging results; neuromuscular neurology seen today. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.4"/>
    <code code="10164-2" codeSystem="2.16.840.1.113883.6.1" displayName="History of Present illness Narrative"/>
    <title>History of Present Illness</title>
    <text><paragraph>Ms. Mankiller returns two weeks after her first visit. On pyridostigmine 30 mg three times daily her eyelids lift for two to three hours after each dose, but double vision returns by evening and her arms still tire when she brushes her hair; she has mild stomach cramps and looser stools after doses. She has had no breathlessness, choking or weak cough. The acetylcholine receptor antibody test is strongly positive. The chest CT and kidney ultrasound were done last week. This morning she saw Dr. Okafor-Delaney of neuromuscular neurology, whose nerve stimulation test showed the typical decrement, and they agreed a plan: a higher pyridostigmine dose, prednisone started low and raised slowly, azathioprine once the screening tests are back, and an assessment for thymectomy. She asked that her blood tests be drawn near home where possible, and wants to understand each medicine before she takes it. She says the polycystic kidney disease is not new to her. [S]</paragraph><table><thead><tr><th>Element</th><th>Detail</th></tr></thead><tbody><tr><td>Diagnosis</td><td>Generalized myasthenia gravis, AChR antibody 6.8 nmol/L, decrement on nerve stimulation; MGFA class IIa; MG-ADL 7</td></tr><tr><td>Imaging</td><td>No thymoma on chest CT; kidney ultrasound: polycystic kidneys, Mayo Imaging Class 1B</td></tr><tr><td>Starting today</td><td>Pyridostigmine 60 mg four times daily; prednisone 10 mg rising weekly; calcium and vitamin D</td></tr><tr><td>Vaccines today</td><td>PCV20 and recombinant zoster dose 1, before immunosuppression</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.18"/>
    <code code="10187-3" codeSystem="2.16.840.1.113883.6.1" displayName="Review of systems Narrative - Reported"/>
    <title>Review of Systems</title>
    <text><table><thead><tr><th>System</th><th>Result</th><th>Finding</th></tr></thead><tbody><tr><td>Eyes</td><td>Positive</td><td>Drooping eyelids and double vision by evening</td></tr><tr><td>Musculoskeletal</td><td>Positive</td><td>Arms and neck tire with use; leg aches after the operations</td></tr><tr><td>Gastrointestinal</td><td>Positive</td><td>Cramps and loose stools after pyridostigmine; no trouble swallowing</td></tr><tr><td>Respiratory</td><td>Negative</td><td>No breathlessness lying flat; cough strong</td></tr><tr><td>Psychiatric</td><td>Negative</td><td>Worried but coping; PHQ-2 score 1</td></tr></tbody></table><paragraph>5 systems reviewed. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.1" extension="2014-06-09"/><templateId root="2.16.840.1.113883.10.20.22.2.1.1" extension="2014-06-09"/>
    <code code="10160-0" codeSystem="2.16.840.1.113883.6.1" displayName="History of Medication use Narrative"/>
    <title>Medications</title>
    <text><table><thead><tr><th>Medication</th><th>Frequency</th><th>Route</th><th>Dates</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="medication-1"><td>Pyridostigmine bromide 30 mg oral tablet, one tablet three times daily with meals as a trial; take 30 to 45 minutes before eating</td><td>One tablet three times daily</td><td>Oral route</td><td>2026-03-09 to 2026-03-23</td><td>completed</td><td>S</td></tr><tr ID="medication-2"><td>Pyridostigmine bromide 60 mg oral tablet, one tablet four times daily while awake, 30 to 45 minutes before meals</td><td>One tablet four times daily while awake</td><td>Oral route</td><td>2026-03-23 to 2026-10-12</td><td>completed</td><td>S</td></tr><tr ID="medication-4"><td>Prednisone 10 mg oral tablet, 10 mg each morning, rising by 10 mg each week to 40 mg each morning, then held at 40 mg</td><td>Once each morning; dose as directed</td><td>Oral route</td><td>2026-03-23 to 2026-07-13</td><td>completed</td><td>S</td></tr><tr ID="medication-7"><td>Calcium carbonate 1250 mg (500 mg elemental calcium) oral tablet, one tablet daily with food</td><td>One tablet daily with food</td><td>Oral route</td><td>2026-03-23</td><td>active</td><td>S</td></tr><tr ID="medication-8"><td>Cholecalciferol (vitamin D3) 1000 units (0.025 mg) oral tablet, one tablet daily</td><td>One tablet daily</td><td>Oral route</td><td>2026-03-23</td><td>active</td><td>S</td></tr><tr ID="medication-10"><td>Acetaminophen 500 mg oral tablet, one or two tablets up to three times daily as needed for leg pain</td><td>One or two tablets up to three times daily as needed</td><td>Oral route</td><td>2025-09-15</td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="3de083a1-dfb1-405d-9475-06b000ffe2aa"/>
      <text><reference value="#medication-1"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260309"/><high value="20260323"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="8" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="903841" codeSystem="2.16.840.1.113883.6.88" displayName="pyridostigmine bromide 30 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="e6236247-eced-46e7-8b55-d5e15baa4463"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="H53.2" codeSystem="2.16.840.1.113883.6.90" displayName="Diplopia"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="ab530837-60d3-4bd5-a729-c5908aeddbc1"/>
      <text><reference value="#medication-2"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260323"/><high value="20261012"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="6" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="903857" codeSystem="2.16.840.1.113883.6.88" displayName="pyridostigmine bromide 60 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="1fb3a7a5-246f-40e1-81cc-368ecbec217d"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="G70.00" codeSystem="2.16.840.1.113883.6.90" displayName="Myasthenia gravis without (acute) exacerbation"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="597b317a-091d-4595-bd73-724f23f27282"/>
      <text><reference value="#medication-4"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260323"/><high value="20260713"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="198145" codeSystem="2.16.840.1.113883.6.88" displayName="prednisone 10 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="8cec7c75-ec08-4910-a6cc-33dcca94c635"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="G70.00" codeSystem="2.16.840.1.113883.6.90" displayName="Myasthenia gravis without (acute) exacerbation"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="cc71ee74-e60c-4397-9735-95b63184338b"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="Z79.52" codeSystem="2.16.840.1.113883.6.90" displayName="Long term (current) use of systemic steroids"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="740250ff-3749-4b1e-b298-8776c7ed1b91"/>
      <text><reference value="#medication-7"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260323"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="282465" codeSystem="2.16.840.1.113883.6.88" displayName="calcium carbonate 1250 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="3e66adb6-33c2-49d0-a865-3f0166b964e2"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="Z79.52" codeSystem="2.16.840.1.113883.6.90" displayName="Long term (current) use of systemic steroids"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="2917a9dc-52b1-4296-9eb1-30a8a76083bb"/>
      <text><reference value="#medication-8"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260323"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="199362" codeSystem="2.16.840.1.113883.6.88" displayName="cholecalciferol 0.025 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="88013abc-f5dc-43ce-a578-0852cc8fb49d"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="Z79.52" codeSystem="2.16.840.1.113883.6.90" displayName="Long term (current) use of systemic steroids"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="b0c5b0a0-09c0-4a33-bdbc-9a051328f5a8"/>
      <text><reference value="#medication-10"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20250915"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="8" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="198440" codeSystem="2.16.840.1.113883.6.88" displayName="acetaminophen 500 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="9b03ca49-c7a0-4883-a355-0f9c4ba6de01"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="Z87.81" codeSystem="2.16.840.1.113883.6.90" displayName="Personal history of (healed) traumatic fracture"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.6" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.6.1" extension="2015-08-01"/>
    <code code="48765-2" codeSystem="2.16.840.1.113883.6.1" displayName="Allergies and adverse reactions Document"/>
    <title>Allergies and Intolerances</title>
    <text><table><thead><tr><th>Allergy</th><th>Reaction</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="allergy-1"><td>No known allergy</td><td></td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.30" extension="2015-08-01"/>
      <id root="34f92ef3-a565-4ed8-adde-491177a70b50"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260309"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN" negationInd="true">
          <templateId root="2.16.840.1.113883.10.20.22.4.7" extension="2014-06-09"/>
          <id root="3c1fbb93-721a-4c30-871e-4554018caad3"/>
          <code code="ASSERTION" codeSystem="2.16.840.1.113883.5.4"/>
          <text><reference value="#allergy-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low nullFlavor="UNK"/></effectiveTime>
          <value xsi:type="CD" code="419199007" codeSystem="2.16.840.1.113883.6.96" displayName="Allergy to substance"/>
          <participant typeCode="CSM"><participantRole classCode="MANU"><playingEntity classCode="MMAT"><code nullFlavor="NA"/></playingEntity></participantRole></participant>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.4" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.4.1" extension="2015-08-01"/>
    <code code="8716-3" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs"/>
    <title>Vital Signs</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="vital-2-1"><td>2026-03-23</td><td>Body height</td><td>163</td><td>cm</td><td>S</td></tr>
  <tr ID="vital-2-2"><td>2026-03-23</td><td>Body weight</td><td>61.6</td><td>kg</td><td>S</td></tr>
  <tr ID="vital-2-3"><td>2026-03-23</td><td>Body mass index (BMI) [Ratio]</td><td>23.2</td><td>kg/m2</td><td>S</td></tr>
  <tr ID="vital-2-4"><td>2026-03-23</td><td>Systolic blood pressure</td><td>124</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-2-5"><td>2026-03-23</td><td>Diastolic blood pressure</td><td>80</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-2-6"><td>2026-03-23</td><td>Heart rate</td><td>76</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-2-7"><td>2026-03-23</td><td>Respiratory rate</td><td>16</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-2-8"><td>2026-03-23</td><td>Body temperature</td><td>36.6</td><td>Cel</td><td>S</td></tr>
  <tr ID="vital-2-9"><td>2026-03-23</td><td>Oxygen saturation in Arterial blood by Pulse oximetry</td><td>98</td><td>%</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.26" extension="2015-08-01"/>
      <id root="afa59dbc-70d0-4bb5-bd65-a8f8e68eba0d"/>
      <code code="74728-7" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs, weight, height, head circumference, oximetry, BMI, and BSA panel - HL7.FHIR.R4"/>
      <statusCode code="completed"/><effectiveTime value="20260323"/>
      <component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="64cf8014-bc55-4654-8ae4-270f475cf211"/><code code="8302-2" codeSystem="2.16.840.1.113883.6.1" displayName="Body height"/><text><reference value="#vital-2-1"/></text><statusCode code="completed"/><effectiveTime value="20260323"/><value xsi:type="PQ" value="163" unit="cm"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="8bc81ef1-7ca7-4190-8dc8-5cb3f4e783c6"/><code code="29463-7" codeSystem="2.16.840.1.113883.6.1" displayName="Body weight"/><text><reference value="#vital-2-2"/></text><statusCode code="completed"/><effectiveTime value="20260323"/><value xsi:type="PQ" value="61.6" unit="kg"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="37c12828-931b-4924-96f2-5b7bcf65fd0c"/><code code="39156-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body mass index (BMI) [Ratio]"/><text><reference value="#vital-2-3"/></text><statusCode code="completed"/><effectiveTime value="20260323"/><value xsi:type="PQ" value="23.2" unit="kg/m2"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="1611b902-af20-4544-b964-c583394485e8"/><code code="8480-6" codeSystem="2.16.840.1.113883.6.1" displayName="Systolic blood pressure"/><text><reference value="#vital-2-4"/></text><statusCode code="completed"/><effectiveTime value="20260323"/><value xsi:type="PQ" value="124" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="9bb086e3-f6b7-4da9-8d22-08028550e7c3"/><code code="8462-4" codeSystem="2.16.840.1.113883.6.1" displayName="Diastolic blood pressure"/><text><reference value="#vital-2-5"/></text><statusCode code="completed"/><effectiveTime value="20260323"/><value xsi:type="PQ" value="80" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="db78332b-962c-4c32-94bd-defb4adc0559"/><code code="8867-4" codeSystem="2.16.840.1.113883.6.1" displayName="Heart rate"/><text><reference value="#vital-2-6"/></text><statusCode code="completed"/><effectiveTime value="20260323"/><value xsi:type="PQ" value="76" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="f528379b-4c67-492f-b7a4-4261ff7d8335"/><code code="9279-1" codeSystem="2.16.840.1.113883.6.1" displayName="Respiratory rate"/><text><reference value="#vital-2-7"/></text><statusCode code="completed"/><effectiveTime value="20260323"/><value xsi:type="PQ" value="16" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="a4d01795-7bb2-4157-be35-25f2746668c8"/><code code="8310-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body temperature"/><text><reference value="#vital-2-8"/></text><statusCode code="completed"/><effectiveTime value="20260323"/><value xsi:type="PQ" value="36.6" unit="Cel"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="9deaaf16-36fa-41b1-bc45-325f033630a6"/><code code="59408-5" codeSystem="2.16.840.1.113883.6.1" displayName="Oxygen saturation in Arterial blood by Pulse oximetry"/><text><reference value="#vital-2-9"/></text><statusCode code="completed"/><effectiveTime value="20260323"/><value xsi:type="PQ" value="98" unit="%"/></observation></component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.3" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.3.1" extension="2015-08-01"/>
    <code code="30954-2" codeSystem="2.16.840.1.113883.6.1" displayName="Relevant Diagnostic Tests and/or Laboratory Data"/>
    <title>Results</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Reference range</th><th>Flag</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="result-19"><td>2026-03-23</td><td>Acetylcholine receptor binding Ab [Moles/volume] in Serum</td><td>6.8</td><td>nmol/L</td><td>0.02 nmol/L or less is negative</td><td>High</td><td>S</td></tr>
  <tr ID="result-20"><td>2026-03-23</td><td>Forced vital capacity [Volume] Respiratory system</td><td>3.25</td><td>L</td><td>Lower limit of normal about 2.9 L for her age, sex and height</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-21"><td>2026-03-23</td><td>Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]</td><td>1</td><td>{score}</td><td></td><td></td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="ef1127d1-fe94-4acc-b997-c82f5d8e1729"/>
      <code code="11034-6" codeSystem="2.16.840.1.113883.6.1" displayName="Acetylcholine receptor binding Ab [Moles/volume] in Serum"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260323"/><high value="20260323"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="21daf352-da97-4ab8-ad77-559bf0a277a5"/>
          <code code="11034-6" codeSystem="2.16.840.1.113883.6.1" displayName="Acetylcholine receptor binding Ab [Moles/volume] in Serum"/>
          <text><reference value="#result-19"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260323"/>
          <value xsi:type="PQ" value="6.8" unit="nmol/L"/>
          <interpretationCode code="H" codeSystem="2.16.840.1.113883.5.83" displayName="High"/>
          <referenceRange>
            <observationRange>
              <text>0.02 nmol/L or less is negative</text>
              <value xsi:type="IVL_PQ"><high value="0.02" unit="nmol/L"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="11bbd9bf-6241-4421-b5b6-9c9ddff00081"/>
      <code code="19870-5" codeSystem="2.16.840.1.113883.6.1" displayName="Forced vital capacity [Volume] Respiratory system"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260323"/><high value="20260323"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="3e02dbca-7676-458f-8167-523356af4063"/>
          <code code="19870-5" codeSystem="2.16.840.1.113883.6.1" displayName="Forced vital capacity [Volume] Respiratory system"/>
          <text><reference value="#result-20"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260323"/>
          <value xsi:type="PQ" value="3.25" unit="L"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>Lower limit of normal about 2.9 L for her age, sex and height</text>
              <value xsi:type="IVL_PQ"><low value="2.9" unit="L"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="3a927154-46aa-4dc1-aaea-4e8d3f782703"/>
      <code code="55758-7" codeSystem="2.16.840.1.113883.6.1" displayName="Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260323"/><high value="20260323"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="56d47256-a579-4808-803b-f06291c27370"/>
          <code code="55758-7" codeSystem="2.16.840.1.113883.6.1" displayName="Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]"/>
          <text><reference value="#result-21"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260323"/>
          <value xsi:type="PQ" value="1" unit="{score}"/>
        </observation>
      </component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.2.10" extension="2015-08-01"/>
    <code code="29545-1" codeSystem="2.16.840.1.113883.6.1" displayName="Physical findings note"/>
    <title>Physical Exam</title>
    <text><paragraph>Vital signs recorded on 2026-03-23; see the Vital Signs section. [S]</paragraph><table><thead><tr><th>System</th><th>Finding</th></tr></thead><tbody><tr><td>General</td><td>Well; blood pressure 124/80 mm Hg</td></tr><tr><td>Eyes</td><td>Left ptosis after 40 seconds of upgaze; diplopia on sustained right gaze</td></tr><tr><td>Neurological</td><td>Neck flexion 4 of 5; deltoids fatigue after 45 seconds of arm abduction; speech becomes nasal after counting to 40; reflexes normal</td></tr><tr><td>Respiratory</td><td>Single-breath count to 30; FVC 3.25 L</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.5" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.5.1" extension="2015-08-01"/>
    <code code="11450-4" codeSystem="2.16.840.1.113883.6.1" displayName="Problem List"/>
    <title>Problems</title>
    <text><table><thead><tr><th>Problem</th><th>Clinical status</th><th>Verification</th><th>Code</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="problem-1">
    <td>Drooping eyelids and double vision for six weeks, worse in the evening, with fatigable weakness of the arms and neck, tiring when chewing and a nasal voice after long talks; a disorder of the neuromuscular junction suspected</td><td>resolved</td><td>confirmed</td>
    <td>H53.2</td><td>S — Synthetic presenting problem, resolved at the second visit when antibodies and nerve testing established myasthenia gravis.</td>
  </tr>
  <tr ID="problem-2">
    <td>Generalized myasthenia gravis, acetylcholine receptor antibody positive, MGFA class IIa, without thymoma; synthetic modern detail linked to her documented myasthenia gravis of 1980</td><td>active</td><td>confirmed</td>
    <td>G70.00</td><td>S — Synthetic antibody level, electrodiagnosis, class and treatment; the diagnosis less than a year after the crash, and recovery with Cherokee medicine people, surgery and drug therapy, are documented (D).</td>
  </tr>
  <tr ID="problem-3">
    <td>Autosomal dominant polycystic kidney disease (hereditary, as she has described it), with normal kidney function; to be staged</td><td>active</td><td>confirmed</td>
    <td>Q61.2</td><td>S — The hereditary polycystic kidney disease is documented (D) from her later public account; its detection before the index date, and every value, are synthetic.</td>
  </tr>
  <tr ID="problem-4">
    <td>Recovery from major trauma in a head-on car crash last year: fractures of both legs, ribs and face, with many operations; walks independently, with a cane on rough ground</td><td>active</td><td>confirmed</td>
    <td>Z87.81</td><td>S — The crash, the operations and the injuries are documented (D); the current function is synthetic.</td>
  </tr>
  <tr ID="problem-5">
    <td>Long-term glucocorticoid therapy for myasthenia gravis, with monitoring of glucose, blood pressure, weight, bone health, mood, sleep, eyes and infection</td><td>active</td><td>confirmed</td>
    <td>Z79.52</td><td>S — Synthetic treatment plan.</td>
  </tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="7e29389b-b6ed-425e-a761-f2b23ca52e1e"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260309"/><high value="20260323"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="89c73303-da81-4fc6-8064-5e3fd4f50a54"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260309"/><high value="20260323"/></effectiveTime>
          <value xsi:type="CD" code="H53.2" codeSystem="2.16.840.1.113883.6.90" displayName="Diplopia"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="a8297c83-5e94-4a36-af8a-412993fd2a61"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260323"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="1938fb8e-d32e-40cd-bc91-a058f521bfde"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-2"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260323"/></effectiveTime>
          <value xsi:type="CD" code="G70.00" codeSystem="2.16.840.1.113883.6.90" displayName="Myasthenia gravis without (acute) exacerbation"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="bafd5325-a8bd-4cc2-a943-c748c49baf92"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260309"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="64aa827c-b151-4a12-8e3b-bae341242107"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-3"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260309"/></effectiveTime>
          <value xsi:type="CD" code="Q61.2" codeSystem="2.16.840.1.113883.6.90" displayName="Polycystic kidney, adult type"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="4fe0389e-703d-4cd8-94b7-22206b8a7800"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260309"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="51d8b68e-08f9-4a8f-b716-239d557ae378"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-4"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260309"/></effectiveTime>
          <value xsi:type="CD" code="Z87.81" codeSystem="2.16.840.1.113883.6.90" displayName="Personal history of (healed) traumatic fracture"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="c9cc67b0-e2a8-434e-9461-579e7089c524"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260323"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="b3e7fb0a-d3fe-48a8-ab81-d09227eedd7c"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-5"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260323"/></effectiveTime>
          <value xsi:type="CD" code="Z79.52" codeSystem="2.16.840.1.113883.6.90" displayName="Long term (current) use of systemic steroids"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.9" extension="2014-06-09"/>
    <code code="51847-2" codeSystem="2.16.840.1.113883.6.1" displayName="Evaluation + Plan note"/>
    <title>Assessment and Plan</title>
    <text><list listType="ordered"><item><content styleCode="Bold">Generalized myasthenia gravis, AChR antibody positive, MGFA class IIa (G70.00)</content>. The diagnosis is confirmed by the antibody and the nerve stimulation decrement; MuSK antibodies and single-fiber EMG are not needed. No thymoma. FVC 3.25 L and negative inspiratory force -68 cm H2O: no sign of impending crisis. [S]<list><item>Pyridostigmine 60 mg four times daily while awake, before meals.</item><item>Prednisone 10 mg each morning, raised by 10 mg each week to 40 mg.</item><item>Azathioprine after TPMT activity and hepatitis B and tuberculosis screening, drawn today.</item><item>Thoracic surgery assessment for robotic thymectomy once stable.</item><item>Crisis warning signs and the list of medicines to avoid reviewed again.</item></list></item><item><content styleCode="Bold">Starting glucocorticoids (Z79.52)</content>. Baseline hemoglobin A1c 5.3 percent, blood pressure 124/80 mm Hg, weight 61.6 kg; a slow start lowers the risk of early worsening. [S]<list><item>Calcium carbonate 1250 mg and cholecalciferol 1000 units daily.</item><item>DXA at the next visit.</item><item>Glucose, blood pressure and weight at each visit.</item></list></item><item><content styleCode="Bold">Autosomal dominant polycystic kidney disease (Q61.2)</content>. Both kidneys enlarged with many cysts; height-adjusted total kidney volume 364 mL/m at 34, Mayo Imaging Class 1B, not rapidly progressive, so tolvaptan is not indicated. eGFR 102 and urine albumin 14 mg/g at the first visit; blood pressure normal-high. [S]<list><item>Home blood pressure readings twice a week; target 110/75 mm Hg or lower if readings exceed 130/85.</item><item>Water 2 to 3 liters a day; less salt; no NSAIDs.</item><item>eGFR and urine albumin yearly.</item></list></item></list><paragraph>Protocol monitoring: items the monitoring protocol calls for at this visit. [S]</paragraph><table><thead><tr><th>Domain</th><th>Measure</th><th>Interval</th><th>Status</th><th>Detail</th></tr></thead><tbody><tr><td>Laboratory</td><td>Acetylcholine receptor binding antibodies</td><td>At diagnosis</td><td>Completed today</td><td>6.8 nmol/L, positive (drawn at the first visit)</td></tr><tr><td>Laboratory</td><td>MuSK antibodies</td><td>If AChR antibodies are negative</td><td>Not indicated</td><td>AChR antibodies positive</td></tr><tr><td>Examination</td><td>Repetitive nerve stimulation</td><td>At diagnosis</td><td>Completed today</td><td>22 percent decrement in the nasalis and 18 percent in the trapezius at neuromuscular neurology</td></tr><tr><td>Examination</td><td>Single-fiber EMG</td><td>If antibodies and nerve stimulation are not diagnostic</td><td>Not indicated</td><td>Diagnosis already confirmed</td></tr><tr><td>Imaging</td><td>CT of the chest for thymoma</td><td>At diagnosis</td><td>Up to date</td><td>Five days ago: no thymoma; residual thymic tissue for age</td></tr><tr><td>Laboratory</td><td>TSH</td><td>At diagnosis</td><td>Up to date</td><td>1.9 mIU/L at the first visit</td></tr><tr><td>Imaging</td><td>Forced vital capacity and negative inspiratory force</td><td>Every visit while weak, and with any breathing or swallowing symptom</td><td>Completed today</td><td>FVC 3.25 L; negative inspiratory force -68 cm H2O; single-breath count 30</td></tr><tr><td>Examination</td><td>Myasthenic crisis warning signs</td><td>Every visit</td><td>Completed today</td><td>No breathlessness lying flat, weak cough, choking or slurred speech; reviewed again with her</td></tr><tr><td>Survey</td><td>MG-ADL score</td><td>Every visit</td><td>Completed today</td><td>7 of 24 (eyelids, double vision, chewing, brushing hair); no LOINC code, so recorded here</td></tr><tr><td>Survey</td><td>Depression screen (PHQ-2)</td><td>At intervals</td><td>Completed today</td><td>PHQ-2 score 1</td></tr><tr><td>Medication safety</td><td>Pyridostigmine side effects</td><td>Every visit</td><td>Completed today</td><td>Cramps and loose stools, mild; taken before meals</td></tr><tr><td>Medication safety</td><td>Medicines that can worsen myasthenia gravis</td><td>At diagnosis and with every new prescription</td><td>Completed today</td><td>Wallet card and list given: fluoroquinolones, aminoglycosides, macrolides, magnesium by vein, beta-blockers, telithromycin and others</td></tr><tr><td>Laboratory</td><td>Screening before immunosuppression: hepatitis B, tuberculosis and TPMT</td><td>Before azathioprine</td><td>Ordered</td><td>Drawn today at the clinic</td></tr><tr><td>Laboratory</td><td>Hemoglobin A1c before glucocorticoids</td><td>Baseline, then periodically</td><td>Up to date</td><td>5.3 percent at the first visit</td></tr><tr><td>Medication safety</td><td>Vaccination before immunosuppression</td><td>Before starting immunosuppressive drugs</td><td>Completed today</td><td>PCV20 and recombinant zoster dose 1 today; no live vaccines from now on</td></tr><tr><td>Medication safety</td><td>Pregnancy and contraception on prednisone and azathioprine</td><td>Before starting and yearly</td><td>Completed today</td><td>Urine pregnancy test negative; she reports reliable contraception; pregnancy to be planned with neuromuscular neurology</td></tr><tr><td>Laboratory</td><td>eGFR and urine albumin-to-creatinine ratio</td><td>Yearly in ADPKD with normal function</td><td>Up to date</td><td>eGFR 102 and urine albumin 14 mg/g at the first visit</td></tr><tr><td>Imaging</td><td>Kidney imaging with total kidney volume (Mayo Imaging Classification)</td><td>At diagnosis or first assessment</td><td>Up to date</td><td>Ultrasound five days ago: htTKV 364 mL/m, class 1B; tolvaptan not indicated</td></tr><tr><td>Examination</td><td>Blood pressure</td><td>Every visit</td><td>Completed today</td><td>124/80 mm Hg in clinic; home readings to start</td></tr><tr><td>Referral</td><td>Neuromuscular neurology</td><td>Once, then through treatment</td><td>Completed today</td><td>Seen today; recommendations in the consultation note</td></tr><tr><td>Referral</td><td>Thoracic surgery for thymectomy</td><td>Once stable</td><td>Ordered</td><td>Assessment visit in about four weeks</td></tr><tr><td>Self-management</td><td>Home blood pressure, water intake, salt, and care close to home</td><td>Every visit</td><td>Completed today</td><td>Home monitor shown; blood tests to be drawn at the Cherokee Nation clinic near her home where possible</td></tr></tbody></table><paragraph>Goal progress:</paragraph><list><item>A confirmed diagnosis and treatment plan within three weeks. Outcome by 2026-03-23: AChR antibodies, nerve stimulation, chest CT and kidney ultrasound done; generalized MG diagnosed and treatment begun at two weeks [S]</item><item>Minimal manifestation status (MG-ADL 0 to 1) within a year, with prednisone at 7.5 mg or less. In progress; target 2026-10-12 [S]</item><item>No myasthenic crisis, and she knows the warning signs and the medicines to avoid. In progress; target 2026-10-12 [S]</item><item>Kidney health: eGFR and urine albumin yearly, home blood pressure 110/75 mm Hg or lower if it rises above 130/85, 2 to 3 liters of water a day, and no NSAIDs. In progress; target 2026-10-12 [S]</item><item>Return to full-time work for the Cherokee Nation. In progress; target 2026-10-12 [S]</item></list><paragraph>Immunizations given today: Pneumococcal conjugate vaccine PCV20, before immunosuppression; Recombinant zoster vaccine, dose 1 of 2, before immunosuppression [S]</paragraph><paragraph>Guideline basis: Narayanaswami P, et al. International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update. Neurology 2021;96(3):114-122 (2020); Sanders DB, et al. International consensus guidance for management of myasthenia gravis: Executive summary. Neurology 2016;87(4):419-425 (2016); Cautionary Drugs (medicines that may worsen myasthenia gravis) (2026); KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD). Kidney Int 2025;107(2S):S1-S239 (2025)</paragraph><paragraph>Follow-up: Neuromuscular neurology nurse call in one week as prednisone rises. Thoracic surgery assessment in about four weeks. Review here in six weeks with blood count, chemistry, FVC and DXA. Next scheduled visit 2026-05-04: six-week review on pyridostigmine and prednisone: strength, breathing, glucose and blood pressure, bone density, start of azathioprine, and the thymectomy plan. [S]</paragraph></text>

  </section>
</component>
    </structuredBody>
  </component>
</ClinicalDocument>
